Forest Laboratories , Inc.

Industry:	Pharmaceuticals, Drug Manufacturing & Research
Ranking:	Russell 3000, Fortune 1000
Revenues:	$3.4 Billion
Employees:	5,126

Description

Forest Laboratories, Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products, which require a physician's prescription, as well as non-prescription pharmaceutical products sold over the counter. The Company's products in the United States consist of branded ethical drug specialties marketed directly or detailed to physicians by its sales forces, Forest Pharmaceuticals, Forest Therapeutics, Forest Healthcare, Forest Ethicare and Forest Specialty Sales. Forest Laboratories, Inc.'s products include Lexapro, the Company's selective serotonin reuptake inhibitor (SSRI) for the treatment of major depression and generalized anxiety disorder (GAD); Namenda, its N-methyl-D-aspartate (NMDA) antagonist for the treatment of moderate to severe Alzheimer's disease; Bystolic, its novel beta-blocker for the treatment of hypertension, and Campral, for the maintenance of alcohol abstinence.
(Source: 10-K)

Products & Services

pharmaceutical products, drug

Find More Jobs

Job Openings

Principal Scientist - Clinical Pharmacology Jersey City , NJ

Sr. Clinical Scientist Jersey City , NJ

Sr. Manager/Manager Regulatory Affairs Jersey City , NJ

Housekeeper Cincinnati , OH

Manager, Medical Writing Jersey City , NJ

View More Statistics

Site Statistics

Monthly Unique Visitors:	38,012
Site Rank:	50,461
Trust Rating:	Trusted
Stats by

News Archive

Forest Laboratories UK Ltd Submits Marketing Authorisation Application for the First Dry Powder Inhalation Antibiotic for Cystic Fibrosis Patients. PR Newswire Europe; 9/15/2009 ...September 15 /PRNewswire/ -- Forest Laboratories UK Ltd, (a wholly owned subsidiary of Forest Laboratories Inc) announced that following...which was wholly developed by Forest Laboratories UK has previously been granted... ...more

Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD. PR Newswire; 8/10/2009 ...PRNewswire-FirstCall/ -- -- Forest Laboratories acquires exclusive commercialisation...III studies -- Access to Forest Laboratories' 2,700-strong US sales...strategy for Daxas Nycomed and Forest Laboratories, Inc. today announced that... ...more

Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation. PR Newswire; 7/10/2009 ...PRNewswire-FirstCall/ -- Forest Laboratories, Inc. and its wholly-owned subsidiary, Forest Laboratories Holdings, Ltd. (collectively...patent litigations. About Forest Laboratories Forest Laboratories is a U... ...more